Altimmune, Inc. (ALT) Tops Q1 EPS by 10c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.40), $0.10 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
• What Delta’s report tells investors in American and United